You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020302051
Dec 20205008
Jan 202167012
Feb 202198021
Mar 2021182040
Apr 2021130044
May 202163028
Jun 20210030
Jul 20210050
Aug 20210033
Sep 20210022
Oct 2021122038
Nov 2021242045
Dec 2021132017
Jan 2022170023
Feb 2022148024
Mar 2022164033
Apr 2022162035
May 2022146026
Jun 2022131012
Jul 2022106013
Aug 202292012
Sep 20226809
Oct 20226209
Nov 20227409
Dec 202280018
Jan 20236004
Feb 20237004
Mar 20235008
Apr 20233808
May 202350010
Jun 202354011
Jul 20237006
Aug 20235003
Sep 20235407
Oct 20235806
Nov 202392015
Dec 202384014
Jan 20247203
Feb 20245004
Mar 20246407
Apr 20247406
May 20247005
Jun 20246208
Jul 20243205
Aug 20244205
Sep 20244005
Oct 20245407
Nov 20244409
Dec 202496011
Jan 20255208
Feb 20251604
Mar 2025008
Apr 20250010
May 2025006
Jun 2025109
Total42900878